As shown with in vitro autoradiography (Additional file1: Figure S9), there was no long-lasting down-regulation of BN2/GRP receptors in the tumour after treatment, which suggests that it is sensible to apply a multiple dosage. The gene discussed is BNC2; the disease is neoplasm.